119 related articles for article (PubMed ID: 34974439)
1. Longitudinal Healthcare Utilization and Costs in Parkinson's Disease: Pre-Diagnosis to 9 Years After.
Soh EML; Neo S; Saffari SE; Wong ASY; Ganesan G; Li W; Ng HL; Xu Z; Tay KY; Au WL; Tan KB; Tan LCS
J Parkinsons Dis; 2022; 12(3):957-966. PubMed ID: 34974439
[TBL] [Abstract][Full Text] [Related]
2. Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK.
Weir S; Samnaliev M; Kuo TC; Tierney TS; Walleser Autiero S; Taylor RS; Schrag A
Mov Disord; 2018 Jul; 33(6):974-981. PubMed ID: 29603405
[TBL] [Abstract][Full Text] [Related]
3. Healthcare utilization in patients with Parkinson's disease: a population-based analysis.
Hobson DE; Lix LM; Azimaee M; Leslie WD; Burchill C; Hobson S
Parkinsonism Relat Disord; 2012 Sep; 18(8):930-5. PubMed ID: 22621819
[TBL] [Abstract][Full Text] [Related]
4. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Parkinson's Disease in Patients with and without Cognitive Impairment.
Chandler JM; Nair R; Biglan K; Ferries EA; Munsie LM; Changamire T; Patel N
J Parkinsons Dis; 2021; 11(3):1381-1392. PubMed ID: 33720850
[TBL] [Abstract][Full Text] [Related]
6. Dying with Parkinson's Disease: Healthcare Utilization and Costs in the Last Year of Life.
Zwicker J; Qureshi D; Talarico R; Webber C; Watt C; Kim W; Milani C; Ramanathan U; Mestre T; Tanuseputro P
J Parkinsons Dis; 2022; 12(7):2249-2259. PubMed ID: 36120791
[TBL] [Abstract][Full Text] [Related]
7. Impact of long-term care insurance on medical costs and utilization by patients with Parkinson's disease.
Kim SH; Park EC; Jang SY
Soc Sci Med; 2023 Jan; 317():115563. PubMed ID: 36455406
[TBL] [Abstract][Full Text] [Related]
8. Matched Cohort Analysis of Total Hip Arthroplasty in Patients With and Without Parkinson's Disease: Complications, Mortality, Length of Stay, and Hospital Charges.
Kleiner JE; Eltorai AEM; Rubin LE; Daniels AH
J Arthroplasty; 2019 Jul; 34(7S):S228-S231. PubMed ID: 30982760
[TBL] [Abstract][Full Text] [Related]
9. Healthcare utilization and costs among women diagnosed with uterine fibroids: a longitudinal evaluation for 5 years pre- and post-diagnosis.
Fuldeore M; Yang H; Soliman AM; Winkel C
Curr Med Res Opin; 2015; 31(9):1719-31. PubMed ID: 26153675
[TBL] [Abstract][Full Text] [Related]
10. Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson's disease.
François C; Biaggioni I; Shibao C; Ogbonnaya A; Shih HC; Farrelly E; Ziemann A; Duhig A
J Med Econ; 2017 May; 20(5):525-532. PubMed ID: 28125950
[TBL] [Abstract][Full Text] [Related]
11. Trends in resource utilization for Parkinson's disease in Germany.
Winter Y; Balzer-Geldsetzer M; von Campenhausen S; Spottke A; Eggert K; Oertel WH; Dodel R
J Neurol Sci; 2010 Jul; 294(1-2):18-22. PubMed ID: 20493500
[TBL] [Abstract][Full Text] [Related]
12. Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases.
Fuldeore M; Yang H; Du EX; Soliman AM; Wu EQ; Winkel C
Fertil Steril; 2015 Jan; 103(1):163-71. PubMed ID: 25455535
[TBL] [Abstract][Full Text] [Related]
13. Effects of physician visit frequency for Parkinson's disease treatment on mortality, hospitalization, and costs: a retrospective cohort study.
Fujita T; Babazono A; Kim SA; Jamal A; Li Y
BMC Geriatr; 2021 Dec; 21(1):707. PubMed ID: 34911495
[TBL] [Abstract][Full Text] [Related]
14. Compliance with pharmacotherapy and direct healthcare costs in patients with Parkinson's disease: a retrospective claims database analysis.
Richy FF; Pietri G; Moran KA; Senior E; Makaroff LE
Appl Health Econ Health Policy; 2013 Aug; 11(4):395-406. PubMed ID: 23649891
[TBL] [Abstract][Full Text] [Related]
15. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B.
Nguyen MH; Burak Ozbay A; Liou I; Meyer N; Gordon SC; Dusheiko G; Lim JK
J Hepatol; 2019 Jan; 70(1):24-32. PubMed ID: 30287341
[TBL] [Abstract][Full Text] [Related]
16. Real-world assessment of "OFF" episode-related healthcare resource utilization among patients with Parkinson's disease in the United States.
Thach A; Jones E; Pappert E; Pike J; Wright J; Gillespie A
J Med Econ; 2021; 24(1):540-549. PubMed ID: 33819121
[TBL] [Abstract][Full Text] [Related]
17. Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohort.
Fernandez HH; Odin P; Standaert DG; Henriksen T; Jimenez-Shahed J; Metz S; Alobaidi A; Yan CH; Kukreja P; Parra JC; Zamudio J; Onuk K; Wright J; Antonini A
Parkinsonism Relat Disord; 2023 Nov; 116():105514. PubMed ID: 37563079
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study.
Lee YY; Tang CH; Chen JH; Kuo LN; Ko Y
Curr Med Res Opin; 2018 Apr; 34(4):735-740. PubMed ID: 29243513
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
20. Real-world health plan claims analysis of differences in healthcare utilization and total cost in patients suffering from cluster headaches and those without headache-related conditions.
Polson M; Lord TC; Evangelatos TM; Lopes M; Santaniello BL
Am J Manag Care; 2017 Nov; 23(16 Suppl):S295-S299. PubMed ID: 29144719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
